CCL2 and atherosclerosis: Chronic leukocyte activation also increases the chemokine secretion (e.g. monocyte chemotactic protein-1 (MCP-1)), which positively associates with systemic inflammation (Papayianni et al. 2002) and may drive atherosclerosis in HD patients (Hu et al. 2016).